Key result
Later COVID-19 waves show significantly lower rates of myocardial complications among fatal cases.
Why the study?
Few studies have compared COVID-19 patients across different pandemic waves.
Does the incidence of myocardial damage in fatal COVID-19 cases decrease across successive pandemic waves?
Cohort (n=276)
No
Does the incidence of myocardial damage in fatal COVID-19 cases decrease across successive pandemic waves?
Myocardial damage in fatal COVID-19 cases, including endotheliitis complications and myocarditis, became less frequent in subsequent pandemic waves.
Answers are grounded in this paper and cite their sources.
Declining myocardial complications in fatal COVID-19 may reflect evolving severity; leaves open confirmation in survivors and mechanisms.
BACKGROUND: Few studies have compared COVID-19 patients from different waves. This study aims to conduct a clinical and morphological analysis of patients who died from COVID-19 during four waves. METHODS: The study involved 276 patients who died from COVID-19 during four waves, including 77 patients in the first wave, 119 patients in the second wave, and 78 patients in the third wave. We performed a histological examination of myocardium samples from autopsies and additionally analyzed the samples by PCR. We conducted immunohistochemistry of the myocardium for 21 samples using antibodies against CD3, CD45, CD8, CD68, CD34, Ang1, VWF, VEGF, HLA-DR, MHC1, C1q, enteroviral VP1, and SARS-CoV-2 spike protein. We also did immunofluorescent staining of three myocardial specimens using VP1/SARS-CoV-2 antibody cocktails. Further, we ran RT-ddPCR analysis for 14 RNA samples extracted from paraffin-embedded myocardium. Electron microscopic studies of the myocardium were also performed for two samples from the fourth wave. RESULTS: Among the 276 cases, active myocarditis was diagnosed in 5% (15/276). Of these cases, 86% of samples expressed VP1, and individual cells contained SARS-CoV-2 spike protein in 22%. Immunofluorescence confirmed the co-localization of VP1 and SARS-CoV-2 spike proteins. ddPCR did not confidently detect SARS-CoV-2 RNA in the myocardium in any myocarditis cases. However, the myocardium sample from wave IV detected a sub-threshold signal of SARS-CoV-2 by qPCR, but myocarditis in this patient was not confirmed. Electron microscopy showed several single particles similar to SARS-CoV-2 virions on the surface of the endothelium of myocardial vessels. A comparison of the cardiovascular complication incidence between three waves revealed that the incidence of hemorrhage (48 vs. 24 vs. 17%), myocardial necrosis (18 vs. 11 vs. 4%), blood clots in the intramural arteries (12 vs. 7 vs. 0%), and myocarditis (19 vs. 1 vs. 6%) decreased over time, and CD8-T-killers appeared. Immunohistochemistry confirmed the presence of endotheliitis in all 21 studied cases. CONCLUSIONS: This study compared myocardial damage in patients who died during three COVID-19 waves and showed a decrease in the incidence of endotheliitis complications (thrombosis, hemorrhage, necrosis) and myocarditis over time. However, the connection between myocarditis and SARS-CoV-2 infection remains unproven.
No takes yet. Share an insight, caveat, or question.
Митрофанова et al. (2023) conducted a cohort in COVID-19 (n=276). Successive COVID-19 pandemic waves vs. First COVID-19 wave was evaluated on Incidence of cardiovascular complications (hemorrhage, myocardial necrosis, blood clots, myocarditis). The incidence of myocardial complications, including hemorrhage, necrosis, thrombosis, and myocarditis, decreased significantly over successive COVID-19 waves among patients who died from the disease.
Synapse has enriched 10 related papers. Consider them for comparative context: